Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.5B | 5.3B | 7.8B | 6.0B |
Cost of revenue | 326M | 289M | 291M | 291M |
Gross profit | 5.2B | 5.0B | 7.5B | 5.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 727M | 728M | 640M | 632M |
Other operating expenses | 3.0B | 2.3B | 4.6B | 3.4B |
Operating income | 1.5B | 1.9B | 2.3B | 1.7B |
Non operating interest income | ||||
Income | 34M | 32M | 46M | 62M |
Expense | 81M | 92M | 82M | 89M |
Other income expense | -305M | -130M | -134M | -249M |
Pretax income | 1.2B | 1.7B | 2.1B | 1.4B |
Tax provision | 243M | 62M | 317M | 261M |
Net income | 938M | 1.7B | 1.8B | 1.2B |
Basic EPS | 0.7 | 2.4 | 1.3 | 1.4 |
Diluted EPS | 0.7 | 2.4 | 1.3 | 1.4 |
Basic average shares | 30.2M | 30.0M | 30.1M | 30.2M |
Diluted average shares | 30.5M | 31.0M | 30.3M | 30.4M |
EBITDA | 1.7B | 2.3B | 2.6B | 2.1B |
Net income from continuing op. | 938M | 1.7B | 1.8B | 1.2B |
Minority interests | -496M | -176M | -958M | -324M |
Preferred stock dividends | 281M | 309M | 291M | 294M |